LON:DNL - Diurnal Group Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 192.50 0.00 (0.00 %)
(As of 06/20/2018 04:00 PM ET)
Previous CloseGBX 192.50
Today's RangeGBX 193.49 - GBX 193.49
52-Week RangeGBX 118 - GBX 215.80
Volume2,577 shs
Average Volume7,428 shs
Market Capitalization£160.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Diurnal Group logoDiurnal Group plc operates as a specialty pharmaceutical company. The company develops hormone therapeutics for the treatment of rare and chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort that is in Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; Rheumacor for the treatment of inflammatory diseases; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism; and siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent cushing's syndrome. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.

Receive DNL News and Ratings via Email

Sign-up to receive the latest news and ratings for DNL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolLON:DNL
CUSIPN/A
Phone+44-29-20682069

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-39.52%
Return on Assets-29.56%

Miscellaneous

EmployeesN/A
Outstanding Shares52,320,000

Diurnal Group (LON:DNL) Frequently Asked Questions

What is Diurnal Group's stock symbol?

Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."

How were Diurnal Group's earnings last quarter?

Diurnal Group (LON:DNL) announced its earnings results on Monday, March, 12th. The company reported ($12.70) earnings per share (EPS) for the quarter. View Diurnal Group's Earnings History.

What price target have analysts set for DNL?

1 analysts have issued 12 month price targets for Diurnal Group's stock. Their forecasts range from GBX 185 to GBX 185. On average, they expect Diurnal Group's share price to reach GBX 185 in the next twelve months. View Analyst Ratings for Diurnal Group.

Who are some of Diurnal Group's key competitors?

Who are Diurnal Group's key executives?

Diurnal Group's management team includes the folowing people:
  • Dr. Martin Whitaker BSc, Ph.D., Chief Exec. Officer and Exec. Director
  • Prof. Richard Ross MBBS, M.D., FRCP, Chief Scientific Officer and Exec. Director
  • Mr. Richard Edward Bungay BSc, ACA, Chief Financial Officer and Director (Age 49)
  • Mr. Michael Withe, Commercial Director
  • Mr. John Porter MBBS, Ph.D., Medical Affairs Director

Has Diurnal Group been receiving favorable news coverage?

Media coverage about DNL stock has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Diurnal Group earned a daily sentiment score of 0.18 on Accern's scale. They also gave press coverage about the company an impact score of 47.89 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Diurnal Group?

Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Diurnal Group's stock price today?

One share of DNL stock can currently be purchased for approximately GBX 192.50.

How big of a company is Diurnal Group?

Diurnal Group has a market capitalization of £160.17 million.

How can I contact Diurnal Group?

Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.


MarketBeat Community Rating for Diurnal Group (DNL)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  110 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  177
MarketBeat's community ratings are surveys of what our community members think about Diurnal Group and other stocks. Vote "Outperform" if you believe DNL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DNL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.